Jean C Solodiuk

Dr. Jean C Solodiuk

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
JSJean C Solodiuk
Jean C Solodiuk

1 November 2014 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
JSJean C Solodiuk
Jean C Solodiuk
HBHadley Brighton
Hadley Brighton
JMJoshua McHale
Joshua McHale
JLJoyce LoChiatto
Joyce LoChiatto
DLDeirdre E. Logan
Deirdre E. Logan
CBCharles B. Berde
Charles B. Berde

17 May 2019 in Brain Sciences
Verified
Journal Article
Open access
PDF file
JSJean C Solodiuk
Jean C Solodiuk
RJRussell William Jennings
Russell William Jennings
DBDusica Bajic
Dusica Bajic
Prolonged sedation in infants leads to a high incidence of physical dependence. We inquired: (1) “How long does it take to develop physical dependence to sedation in previously naïve full-term infants without known history of neurologic impairment?” and (2) “What is the relationship between length of sedation to length of weaning and hospital stay?”. The retrospective study included full-term patients over a period of one year that were 72 hours. Quantification of fentanyl, morphine, and midazolam were compared among three time periods: 30 days using t-test or one-way analysis of variance. Identified full-term infants were categorized into surgical (14/44) or medical (10/44) groups, while those with neurological involvement (20/44) were excluded. Physical dependence in full-term infants occurred following sedation ≥5 days. Infants with surgical disease received escalating doses of morphine and midazolam when administered >30 days. A positive association between length of sedation and weaning period was found for both respiratory (p < 0.01) and surgical disease (p = 0.012) groups, while length of sedation is related to hospital stay for the respiratory (p < 0.01) but not the surgical disease group (p = 0.1). Future pharmacological directions should lead to standardized sedation protocols and evaluate patient neurocognitive outcomes.

1 November 2019 in Journal of Pediatric Nursing
Verified
Journal Article
Closed access
JSJean C Solodiuk
Jean C Solodiuk
CGChristine D. Greco
Christine D. Greco
KOKatherine A. O'DOnnell
Katherine A. O'DOnnell
DMDominick R. Morrill
Dominick R. Morrill
MCMartha A.Q. Curley
Martha A.Q. Curley

3 December 2024 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
JSJean C Solodiuk
Jean C Solodiuk
CDCarolina Md Donado
Carolina Md Donado
LWLia Msn Wickerham
Lia Msn Wickerham
LGLindsay Msn Goodyear
Lindsay Msn Goodyear
JHJohn Rn Hayes
John Rn Hayes
MCMartha A. Q. RN Curley
Martha A. Q. RN Curley
OBJECTIVES: To develop and conduct preliminary testing of the Withdrawal Assessment Tool-Alpha 2 Agonist (WAT-A2A) to monitor dexmedetomidine and clonidine withdrawal symptoms in acutely ill children. DESIGN: Three-phase instrument development study. Phase 1: retrospective chart review of symptoms exhibited by children with documented dexmedetomidine withdrawal; phase 2: WAT-A2A instrument construction based on phase 1 data; and phase 3: prospective testing of the WAT-A2A in children weaning from alpha 2 agonists (A2As). SETTING: Academic free-standing children’s hospital. PATIENTS: Acutely ill children weaning from at least 5 days of dexmedetomidine. Excluded were children concurrently weaning other sedatives. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Phase 1: In 83 of 303 children weaning from at least 5 days of dexmedetomidine who had clinician documentation and were managed for A2A withdrawal, 88% (n = 72) exhibited at least a 20% increase in heart rate (HR), 83% (n = 69) exhibited agitation or change in usual state behavior, 46% (n = 38) exhibited at least a 20% increase in diastolic blood pressure (DBP), and when documented, 56% (27/48) exhibited tremors during their A2A withdrawal episode. Phase 2: The WAT-A2A was constructed, based on phase 1 data, and includes four items: HR, state behavior, DBP, and tremors. Phase 3: The WAT-A2A was tested and performed well in 82 children weaning from A2A. The total WAT-A2A score correlated with clinician subjective assessment of A2A withdrawal (Spearman correlation = 0.5; p < 0.001). Inter-rater agreement, comparing paired ratings of prospectively collected WAT-A2A data, indicated moderate inter-rater reliability. CONCLUSIONS: Acutely ill children receiving sedation with an A2A for more than 5 days may develop physiologic dependence, requiring gradual dosing reductions. While further psychometric testing is advised, the WAT-A2A provides an objective instrument to help clinicians quantify dexmedetomidine withdrawal symptoms in acutely ill children may facilitate A2A weaning and limit unnecessary variation in practice.

1 August 2020 in Creative Nursing
Verified
Journal Article
Closed access
PDF file
JSJean C Solodiuk
Jean C Solodiuk
BJBrian Jantz
Brian Jantz
MFMark Fuller
Mark Fuller
DODana Osterling
Dana Osterling
HFHannah Foxman
Hannah Foxman
SHSuzanne Hanser
Suzanne Hanser
Pain is common and often severe in people with sickle cell disease (SCD), occurring as acute intermittent pain episodes called vaso-occlusive episodes (VOEs), as well as chronic pain conditions including bone infarctions, avascular necrosis of joints, and neuropathic pain. Analgesics such as opioids, nonsteroidal anti-inflammatory medications (NSAIDS), and anticonvulsants for neuropathic pain, although often necessary to manage these types of pain, are associated with side effects. Nonpharmacologic interventions such as to listening to music and music therapy may reduce pain. The objectives of this study were to determine whether the use of music by adolescents and young adults with SCD was helpful, and if so, the types of music that helped, and how music helped them. A convenience sample of nine English-speaking inpatients ages 13 to 21 years, with SCD and at least two prior hospitalizations for VOE, took part in interviews with music therapists. Participants were asked open-ended questions about both pain and music. Participants identified that music was helpful for pain relief as well as for mood regulation, focusing attention during cognitive tasks such as homework, distraction, relaxation, and feeling understood or connected with others. Despite this, while hospitalized, participants reported that they did not tend to use music to help with pain. These findings support the use of both music medicine and music therapy as interventions for pain and distress in adolescents and young adults with SCD.